Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
SkinBioTherapeutics PLC (GB:SBTX)
LSE:SBTX
Holding GB:SBTX?
Track your performance easily
SBTX Stock Chart & Stats
Day’s Range― - ―
52-Week Range7.00p - 19.75p
Previous CloseN/A
Volume282.34K
Average Volume (3M)825.67K
Market Cap
£34.84M
Enterprise Value17.10M
Total Cash (Recent Filing)$3.92M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.41
Next Earnings
Apr 01, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding228,435,910
10 Day Avg. Volume486,580
30 Day Avg. Volume825,670
Standard Deviation0.34
R-Squared0.08
Alpha0.04
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)236.02
Price to Cash Flow (P/CF)-14.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.49
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit200.78
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
SkinBioTherapeutics News
PremiumCompany Announcements
SkinBioTherapeutics Announces Change in Major Holdings
PremiumCompany Announcements
SkinBioTherapeutics Expands in Skin Health Market
PremiumCompany Announcements
SkinBioTherapeutics Projects Strong FY25 Growth Amidst Expansion
PremiumCompany Announcements
SkinBioTherapeutics Delays Results, Eyes Market Expansion
PremiumCompany Announcements
SkinBioTherapeutics to Announce Full-Year ResultsPremiumCompany Announcements
SkinBioTherapeutics and Croda Secure Key Commercial Deal
PremiumCompany Announcements
SkinBioTherapeutics Voting Rights Shift Slightly
PremiumCompany Announcements
SkinBioTherapeutics Expands with Strategic Acquisitions and GrowthSBTX FAQ
What was SkinBioTherapeutics PLC’s price range in the past 12 months?
SkinBioTherapeutics PLC lowest share price was 7.00p and its highest was 19.75p in the past 12 months.
What is SkinBioTherapeutics PLC’s market cap?
SkinBioTherapeutics PLC’s market cap is £34.84M.
When is SkinBioTherapeutics PLC’s upcoming earnings report date?
SkinBioTherapeutics PLC’s upcoming earnings report date is Apr 01, 2025 which is in 71 days.
How were SkinBioTherapeutics PLC’s earnings last quarter?
SkinBioTherapeutics PLC released its earnings results on Dec 04, 2024. The company reported -0.008p earnings per share for the quarter, missing the consensus estimate of N/A by -0.008p.
Is SkinBioTherapeutics PLC overvalued?
According to Wall Street analysts SkinBioTherapeutics PLC’s price is currently Overvalued.
Does SkinBioTherapeutics PLC pay dividends?
SkinBioTherapeutics PLC does not currently pay dividends.
What is SkinBioTherapeutics PLC’s EPS estimate?
SkinBioTherapeutics PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SkinBioTherapeutics PLC have?
SkinBioTherapeutics PLC has 228,435,910 shares outstanding.
What happened to SkinBioTherapeutics PLC’s price movement after its last earnings report?
SkinBioTherapeutics PLC reported an EPS of -0.008p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -5.836%.
Which hedge fund is a major shareholder of SkinBioTherapeutics PLC?
Currently, no hedge funds are holding shares in GB:SBTX
---
SkinBioTherapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
10.65%
12-Months-Change
Fundamentals
Return on Equity
-115.86%
Trailing 12-Months
Asset Growth
101.02%
Trailing 12-Months
Company Description
SkinBioTherapeutics PLC
SkinBioTherapeutics PLC is a life science company focused on skin health. It is focused on the development of technology to protect, manage and restore skin utilizing proteins found in the human microbiota. SkinBioTherapeutics is targeting three specific skin healthcare sectors; cosmetics, infection control, and eczema. The company has one reportable segment namely the research and development of the SkinBiotix technology.
---
Technical Analysis
Futura Medical
―
Abingdon Health PLC
―
HemoGenyx Pharmaceuticals Plc
―
RUA Life Sciences
―
Synairgen
―
---